Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
Isabella Ruggeri,1 Donatello Bragato,2 Giorgio L Colombo,3,4 Emanuela Valla,3 Sergio Di Matteo41Servizio Governo Area Farmaceutica, Azienda Sanitaria Locale, Milano, Binasco, 2Data Solution Provider, Milan, 3University of Pavia, Department of Drug Sciences, School of Pharmacy, 4Studi Analisi Valutaz...
Main Authors: | Ruggeri I, Bragato D, Colombo GL, Valla E, Di Matteo S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-12-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/cost-and-appropriateness-of-treating-asthma-with-fixed-combination-dru-a11686 |
Similar Items
-
Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study
by: Canonica GW, et al.
Published: (2020-01-01) -
Factors Associated with the Appropriate Use of Asthma Drugs
by: Marie-Sophie Jobin, et al.
Published: (2011-01-01) -
Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy
by: Colombo GL, et al.
Published: (2012-07-01) -
The health and social costs of chronic kidney disease in Italy
by: Americo Cicchetti, et al.
Published: (2011-11-01) -
FIXED ETIOPATHOGENETIC COMBINATION OF DRUGS TO TREAT ARTERIAL HYPERTENSION
by: M. P. Savenkov, et al.
Published: (2017-07-01)